Advancements in technology have opened new possibilities in diabetes management—and companies around the world are vying for a piece of the pie.
Silicon Valley has been exploring avenues into healthcare in many ways, but advancements in diabetes management are poised to make an impact in self-regulating chronic diseases. Replacing fingerpricks with continuous monitoring and inaccurate blood sugar measurements with sensor readings, these technologies are enabling patients to take charge of their own care.
“Companies who succeed will be those who can figure out this convergence of health care and technology,” said Arda Ural, a partner at Ernst & Young LLP in New York. “And they’re very different animals to bring together.”
Read the full story below: